CLINICAL_TRIALS
trial_result
· 2024-03-07
Clinical Trial Update: Study of DS-5141b in Patients With Duchenne Muscular Dystrophy [Phase 1, Phase 2]
Summary
Phase 1/2 study of DS-5141b in Duchenne Muscular Dystrophy has completed; results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-03-07